about
Risk of hyperkalemia and combined use of spironolactone and long-term ACE inhibitor/angiotensin receptor blocker therapy in heart failure using real-life data: a population- and insurance-based cohort.Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes.Lipids, blood pressure, kidney - what was new in 2011?Short-term mortality risk of serum potassium levels in acute heart failure following myocardial infarctionMedication management of chronic heart failure in older adults.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
What is the risk of hyperkalaemia in heart failure?
@en
What is the risk of hyperkalaemia in heart failure?
@nl
type
label
What is the risk of hyperkalaemia in heart failure?
@en
What is the risk of hyperkalaemia in heart failure?
@nl
prefLabel
What is the risk of hyperkalaemia in heart failure?
@en
What is the risk of hyperkalaemia in heart failure?
@nl
P2860
P50
P1476
What is the risk of hyperkalaemia in heart failure?
@en
P2093
Jacek Rysz
P2860
P304
P356
10.1517/14656566.2011.601743
P407
P577
2011-07-19T00:00:00Z